Takahiro Ozasa, Masao Nakajima, Ryouichi Tsunedomi, Shunsuke Goto, Keishi Adachi, Hidenori Takahashi, Koji Tamada, Hiroaki Nagano. "Novel immune drug combination induces tumour microenvironment remodelling and reduces the dosage of anti-PD-1 antibody." Scientific Reports, 2025. doi:10.1038/s41598-025-87344-6